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Abbreviations 
 
bp: base pair 
FL: full length 
nt: nucleotide 
ROI: read of insert, i.e. PacBio read 
SJ: splice junction 
SMRT: single-molecule real-time 
TM: transcript model 
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Abstract 
 
Accurate annotations of genes and their transcripts is a foundation of genomics, but no 
annotation technique presently combines throughput and accuracy. As a result, reference 
gene collections remain incomplete: many gene models are fragmentary, while thousands 
more remain uncatalogued—particularly for long noncoding RNAs (lncRNAs). To 
accelerate lncRNA annotation, the GENCODE consortium has developed RNA Capture 
Long Seq (CLS), combining targeted RNA capture with third-generation long-read 
sequencing. We present an experimental re-annotation of the GENCODE intergenic 
lncRNA population in matched human and mouse tissues, resulting in novel transcript 
models for 3574 / 561 gene loci, respectively. CLS approximately doubles the annotated 
complexity of targeted loci, outperforming existing short-read techniques. Full-length 
transcript models produced by CLS enable us to definitively characterize the genomic 
features of lncRNAs, including promoter- and gene-structure, and protein-coding 
potential. Thus CLS removes a longstanding bottleneck of transcriptome annotation, 
generating manual-quality full-length transcript models at high-throughput scales. 
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Introduction 
 
Long noncoding RNAs (lncRNAs) represent a vast and largely unexplored 
component of the mammalian genome. Efforts to assign lncRNA functions rest on the 
availability of high-quality transcriptome annotations. At present such annotations are 
still rudimentary: we have little idea of the total lncRNA count, and for those that have 
been identified, transcript structures remain largely incomplete.  
 The number and size of available lncRNA annotations have grown rapidly thanks 
to projects using diverse approaches. Early gene sets, deriving from a mixture of 
FANTOM cDNA sequencing efforts and public databases1,2 were joined by the 
“lincRNA” (long intergenic non-coding RNA) sets, discovered through chromatin 
signatures3. More recently, studies have applied transcript-reconstruction software, such 
as Cufflinks4  to identify novel genes in short-read RNA sequencing (RNAseq) datasets5–
9. However the reference for lncRNAs has become the regularly-updated, manual 
annotations from GENCODE, based on curation of cDNAs/ESTs by human 
annotators10,11, and adopted by international genomics consortia12–15.  
At present, annotation efforts are caught in a trade-off between throughput and 
quality. Short read-based transcriptome reconstruction methods deliver large annotations 
with low financial and time investment. Manual annotation is slow and requires long-
term funding. However the quality of software-reconstructed annotations is often 
doubtful, due to the inherent difficulty of reconstructing transcript structures from shorter 
sequence reads. Such structures tend to be incomplete, often lacking terminal exons or 
omitting splice junctions between adjacent exons16. This particularly affects lncRNAs, 
whose low expression results in low read coverage11. The outcome is a growing 
divergence between large automated annotations of uncertain quality (e.g. 101,700 genes 
for NONCODE8), and the highly-curated “conservative” GENCODE collection11 (15,767 
genes for version 25).  
 Annotation incompleteness takes two forms. First, genes may be entirely missing 
from the annotation: many genomic regions are suspected to transcribe RNA but contain 
no annotation, including “orphan” small RNAs with presumed long precursors17, 
enhancers18 and ultraconserved elements19,20. Second, annotated lncRNAs may represent 
partial gene structures. Start and end sites frequently lack independent supporting 
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evidence11, and lncRNAs are shorter and have fewer exons than mRNAs7,11,21. Recently, 
RACE-Seq was developed to complete lncRNA annotations, but at relatively low 
throughput21. 
One of the principal impediments to lncRNA annotation arises from their low 
steady-state levels3,11. To overcome this, “RNA Capture Sequencing” (CaptureSeq)22 is 
used to boost the concentration of low-abundance transcripts in cDNA libraries. These 
studies depend on short-read sequencing and in-silico transcript reconstruction22–24. Thus, 
while CaptureSeq achieves high throughput, its transcript structures lack the confidence 
required for inclusion in GENCODE. 
In this study, we describe a new method called RNA Capture Long Seq (CLS), 
which couples targeted RNA capture with third-generation long-read cDNA sequencing. 
We use CLS to interrogate the GENCODE catalogue of intergenic lncRNAs, together 
with thousands of suspected novel loci, in six tissues each of human and mouse. CLS 
couples the throughput of CaptureSeq with high-confidence, complete transcript models 
from long-read sequencing, resulting in a significant advance in transcriptome annotation.  
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Results 
 
Capture Long Seq approach to complete lncRNA annotations 
 
Our aim was to develop an experimental approach to improve and extend reference 
transcript annotations, while minimizing human intervention and avoiding in-silico 
transcript assembly. We designed a method, Capture Long Seq (CLS), which couples 
targeted RNA capture to Pacific Biosciences (“PacBio”) Third Generation long-read 
sequencing (Figure 1a).  
CLS may be applied to two distinct objectives: to improve existing gene models, 
or to identify novel loci (blue and orange in Figure 1a, respectively). Although the present 
study focuses mainly on the former, we demonstrate also that novel loci can be captured 
and sequenced. We created a comprehensive capture library targeting the set of intergenic 
GENCODE lncRNAs in human and mouse. Note that annotations for human are presently 
more complete than for mouse, resulting in different annotation sizes (14,470 vs 5,385 
lncRNA genes in GENCODE releases 20 and M3, respectively). GENCODE annotations 
probed in this study are principally multi-exonic transcripts based on polyA+ cDNA/EST 
libraries, and hence not likely to include “enhancer RNAs”10,25. To these we added tiled 
probes targeting loci that may produce lncRNAs: small RNA genes26, enhancers27 and 
ultraconserved elements28. For mouse we also added orthologous lncRNA predictions 
from PipeR29. Numerous control probes were added, including a series targeting half of 
the ERCC synthetic spike-ins30. These sequences were targeted by capture libraries of 
temperature-matched and non-repetitive oligonucleotide probes (Figure 1b). 
To access the maximal lncRNA diversity, we chose transcriptionally complex and 
biomedically-relevant organs from mouse and human: whole brain, heart, liver and testis 
(Figure 1c). We added two deeply-studied human cell lines, HeLa and K56231, and two 
mouse embryonic time-points (E7 and E15).  
We designed a protocol to capture full-length, oligo-dT-primed cDNAs (see 
Methods). Barcoded, unfragmented cDNAs were pooled and captured. Preliminary tests 
using qPCR indicated enrichment for targeted regions (Supplementary Figure 1a). PacBio 
sequencing tends to favour shorter templates in a mixture32. Therefore pooled, captured 
cDNA was size-selected into three ranges (1-1.5kb, 1.5-2.5kb, >2.5kb) (Supplementary 
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Figure 1b-c), and used to construct sequencing libraries for PacBio SMRT (single-
molecular real-time) technology33. 
 
CLS yields an enriched long-read transcriptome 
 
Samples were sequenced on 130 SMRT cells, yielding ~2 million reads in total in 
each species (Figure 2a). PacBio reads, or “reads of insert” (ROIs) were demultiplexed to 
retrieve their tissue of origin and mapped to the genome. We observed high mapping rates 
(>99% in both cases), of which 86% and 88% were unique, in human and mouse, 
respectively (Supplementary Figure 2a). For brevity, all data are henceforth quoted in 
order of human then mouse. The use of short barcodes meant that, for ~30% of reads, the 
tissue of origin could not be retrieved (Supplementary Figure 2b). This may be remedied 
by the use of longer barcodes. Representation was even across tissues, with the exception 
of testis (Supplementary Figure 2d). ROIs had a median length of 1 - 1.5 kb (Figure 2b) 
consistent with previous reports32 and exceeding average lncRNA annotation of ~0.5 kb11. 
Capture performance is assessed in two ways: by “on-target” rate – the proportion 
of reads originating from probed regions – and by enrichment, or increase of on-target 
rate following capture34. To estimate these, we sequenced pre- and post-capture libraries 
using MiSeq. CLS achieved on-target rates of 29.7% / 16.5%, representing 19- / 11-fold 
enrichment (Figure 2c, d and Supplementary Figure 2e). These rates are competitive with 
intergenic lncRNA capture in previous, short-read studies (Supplementary Figure 2f-g). 
The majority of off-target signal arises from non-targeted, annotated protein-coding genes 
(Figure 2c). 
CLS on-target rates were comparable to previous studies using fragmented 
cDNA35(Supplementary Figure 2f-g), although lower than genomic DNA capture. Side-
by-side comparisons showed that capturing long cDNA fragments implies some loss in 
capture efficiency (Supplementary Figure 2h-i), as observed by others24. 
 Synthetic spike-in sequences at known concentrations were used to assess 
sensitivity and quantitativeness. We compared the relationship of sequence reads to 
starting concentration for the 42 probed (green) and 50 non-probed (violet) synthetic 
ERCC sequences in pre- and post-capture samples (Figure 2e, top and bottom rows). CLS 
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is surprisingly sensitive, extending detection sensitivity by two orders of magnitude, and 
capable of detecting molecules at approximately 5 x 10-3 copies per cell (Methods). It is 
less quantitative than CaptureSeq24, particularly at higher concentrations where the slope 
falls below unity. This suggests saturation of probes by cDNA molecules during 
hybridisation. A degree of noise, as inferred by the coefficient of determination (R2) 
between read counts and template concentration, is introduced by the capture process.  
 
CLS expands the complexity of known and novel lncRNAs 
 
CLS discovers a wealth of novel transcript structures within annotated lncRNA 
loci. In the SAMMSON oncogene36 (LINC01212), we discover new exons, splice sites, 
and transcription termination sites compared to present annotations (Figure 3a, more 
examples in Supplementary Figures 3, 4, 5, which could be validated by RT-PCR). 
We measured the amount of new complexity discovered in targeted lncRNA loci. 
CLS detected 58% and 45% of targeted lncRNA nucleotides, and extended these 
annotations by 6.3 / 1.6 Mb nucleotides (86% / 64% increase compared to existing 
annotations) (Supplementary Figure 6a). CLS discovered 45,673 and 11,038 distinct 
splice junctions (SJs), of which 36,839 and 8,847 are novel (Figure 3b and Supplementary 
Figure 6b, left bars). The number of novel, high-confidence SJs amounted to 20,327 when 
compared to a deeper human SJ reference catalogue composed of both GENCODE v20 
and miTranscriptome7 (Supplementary Figure 6c). For independent validation, and given 
the relatively high sequence indel rate detected in PacBio reads (Supplementary Figure 
2m) (see Methods for analysis of sequencing error rates), we deeply sequenced captured 
cDNA by Illumina HiSeq at an average depth of 35 million / 26 million pair-end reads 
per sample. Split reads from this data exactly matched 78% / 75% SJs from CLS. These 
“high-confidence” SJs alone represent a 160% / 111% increase over the existing, probed 
annotations (Figure 3b, Supplementary Figure 6b). Novel high-confidence lncRNA SJs 
are rather tissue-specific, with greatest numbers observed in testis (Supplementary Figure 
6d), and were also discovered across other classes of targeted and non-targeted loci 
(Supplementary Figure 6e). We observed a greater frequency of intron retention events 
in lncRNAs, compared to protein-coding transcripts (Supplementary Figure 6f). 
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To evaluate the biological significance of novel lncRNA SJs, we computed their 
strength using standard position weight matrix models37 (Figure 3c, Supplementary 
Figure 7a). High-confidence novel SJs from lncRNAs (orange, upper panel) far exceed 
the predicted strength of background SJ-like dinucleotides (bottom panels), and are 
essentially indistinguishable from annotated SJs (pink, upper and middle panels). Even 
unsupported, novel SJs (black) tend to have high scores, although with a significant low-
scoring tail. Although they display little evidence of sequence conservation using 
standard measures (similar to lncRNA SJs in general) (Supplementary Figure 7b), novel 
SJs also display weak but non-random evidence of selected function (Supplementary 
Figure 7c). 
We estimated how close these sequencing data are to saturation, i.e., to reaching 
a definitive annotation. We tested the rate of novel splice junction and transcript model 
discovery as a function of increasing depth of randomly-sampled ROIs (Figure 3d, 
Supplementary Figures 8a-b). We observed an ongoing gain of novelty with increasing 
depth, for both low- and high-confidence SJs, up to that presented here. Similarly, no SJ 
discovery saturation plateau was reached at increasing simulated HiSeq read depth 
(Supplementary Figure 8c). Thus, considerable additional sequencing is required to 
complete existing lncRNA gene structures. 
Beyond lncRNAs, CLS can be used to characterize other types of transcriptional 
units.  As an illustration, we searched for precursors of small RNAs, whose annotation 
remains poor17. We probed 1 kb windows around all “orphan” small RNAs, i.e. those 
with no annotated overlapping transcript. Note that, although mature snoRNAs are non-
polyadenylated, they are processed from polyA+ precursors38. We identified more than 
one hundred likely primary transcripts, and hundreds more potential precursors 
harbouring small RNAs within their introns (Figure 3e). One intriguing example was the 
cardiac-enriched hsa-mir-143, for which CLS identifies a new RT-PCR-supported 
primary transcript that belongs to the CARMEN1 lncRNA gene39 (Supplementary Figure 
9). 
 
Assembling a full-length lncRNA annotation 
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 A unique benefit of the CLS approach is the ability to identify full-length 
transcript models with confident 5’ and 3’ termini. ROIs of oligo-dT-primed cDNAs carry 
a fragment of the poly(A) tail, which can identify the polyadenylation site with basepair 
precision32. Using conservative filters, 73% / 64% of ROIs had identifiable polyA sites 
(Supplementary Table 1) representing 16,961 / 12,894 novel sites when compared to end 
positions of GENCODE annotations. Known and novel polyA sites were preceded by 
canonical polyadenylation motifs (Supplementary Figure 10a-d). Similarly, the 5’ 
completeness of ROIs was confirmed by proximity to methyl-guanosine caps identified 
by CAGE (Cap Analysis of Gene Expression)15 (Supplementary Figure 10e). CAGE and 
polyA sites were used to define the 5’ / 3’ completeness of all ROIs (Figure 4a). 
We developed a pipeline to merge ROIs into a non-redundant collection of 
transcript models (TMs). In contrast to previous approaches4, our “anchored merging” 
method preserves confirmed internal TSS or polyA sites (Figure 4b). Applying this to 
captured ROIs results in a greater number of unique TMs than would be identified 
otherwise (Figure 4c, Supplementary Figure 11a). We identified 179,993 / 129,556 
transcript models across all biotypes (Supplementary Table 2), 86 / 87% of which 
displayed support of their entire intron chain by captured HiSeq split reads 
(Supplementary Table 3). In the heavily-studied CCAT1 locus40, novel full-length 
transcripts with 5’ and 3’ support were identified (Figure 4d). CLS here suggests that 
adjacent CCAT1 and CASC19 annotations are fragments of a single gene, a conclusion 
supported by RT-PCR (Figure 4d). 
Merged TMs can be defined by their end support: full length (“FL”, 5’ and 3’ 
supported), 5’ only, 3’ only, or unsupported (Figure 4b,e). We identified a total of 65,736 
/ 44,673 FL transcript models (Figure 4e and Supplementary Figure 11b, left panels): 
47,672 (73%) / 37,244 (83%) arise from protein coding genes, and 13,071 (20%) / 5,329 
(12%) from lncRNAs (Supplementary Table 2). An additional 3,742 (6%) / 1,258 (3%) 
represent FL models that span loci of different biotypes (listed in Figure 1b), usually 
including one protein-coding gene (“Multi-Biotype”). Of the remaining non-coding FL 
transcript models, 295 / 434 are novel, arising from unannotated gene loci. Altogether, 
11,429 / 4,350 full-length structures arise from probed lncRNA loci, of which 8,494 / 
3,168 (74% / 73%) are novel (Supplementary Table 2). We identified at least one FL TM 
for 19% / 12% of the originally-probed lncRNA annotation (Figure 4f, Supplementary 
Figure 11c). Independent evidence for gene promoters from DNaseI hypersensitivity 
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sites, supported our 5’ identification strategy (Figure 4g). Human lncRNAs with mouse 
orthologues had significantly more FL TMs, although the reciprocal was not observed 
(Supplementary Figure 11d-g). This imbalance may be due to evolutionary factors (e.g. 
the appearance of novel lncRNA isoform complexity during primate evolution), or 
technical biases: it is noteworthy that we had access to deeper CAGE data in human than 
in mouse (217,516 vs 129,465 TSSs), and that human lncRNA annotations are more 
complete than for mouse. 
In addition to probed lncRNA loci, CLS also discovered several thousand novel 
TMs originating from unannotated regions, mapping to probed (blue in Figure 1b) or 
unprobed regions (Supplementary Figures 11h-i). These TMs tended to have lower 
detection rates (Supplementary Figure 11j) consistent with low overall expression 
(Supplementary Figure 11k) and lower rates of 5’ and 3’ support than probed lncRNAs, 
although a small number are full length (“other” in Figure 4e and Supplementary Figure 
11b, right panels).  
We next compared CLS performance to the conventional, short-read CaptureSeq 
methodology. We took advantage of our HiSeq analysis (212/156 million reads, in 
human/mouse) of the same captured cDNAs, to make a fair comparison between methods. 
Short-read methods depend on in-silico transcriptome assembly: we found, using PacBio 
reads as a reference, that the recent StringTie tool outperforms Cufflinks, used in previous 
CaptureSeq projects24,41 (Supplementary Figure 12a). Using intron chains to compare 
annotations, we found that CLS identifies 69% / 114% more novel TMs than StringTie 
assembly (Figure 4h and Supplementary Figure 12b). CLS TMs are more complete at 5’ 
and 3’ ends than StringTie assemblies, and more complete at the 3’ end compared to 
probed GENCODE annotations (Figure 4i and Supplementary Figures 12d-h). Thus, 
although StringTie TMs are slightly longer (Figure 4j and Supplementary Figure 12c), 
they are far less likely to be full-length than CLS. This greater length may be due to 
StringTie producing overly long 5’ extensions, as suggested by the relatively high CAGE 
signal density downstream of StringTie TSSs (Supplementary Figure 12g-h). CLS is more 
sensitive in the detection of repetitive regions, identifying in human approximately 20% 
more repetitive nucleotides (Supplementary Figure 12i). 
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Re-defining lncRNA promoter and gene characteristics 
 
With a full-length lncRNA catalogue, we revisited the basic characteristics of 
lncRNA and protein-coding genes. LncRNA transcripts, as annotated, are significantly 
shorter and have less exons than mRNAs5,11. However it has remained unresolved 
whether this is a genuine biological trend, or simply the result of annotation 
incompleteness21. Considering FL TMs from CLS, we find that the median lncRNA 
transcript to be 1108 / 1067 nt, similar to mRNAs mapped by the same criteria (1240 / 
1320 nt) (Figure 5a, Supplementary Figure 13a). This length difference of 11% / 19% is 
statistically significant (P<2x10-16 for human and mouse, two-sided Wilcoxon test). These 
measured lengths are still shorter than most annotated protein-coding transcripts (median 
1,543 nt in GENCODE v20), but much larger than annotated lncRNAs (median 668 nt). 
There are two factors that preclude our making firm statements regarding relative lengths 
of lncRNAs and mRNAs: first, the upper length limitation of PacBio reads (Figure 2b); 
second, the fact that our size-selection protocol selects against shorter transcripts. 
Nevertheless we do not find evidence that lncRNAs are substantially shorter11. We expect 
that this issue will be definitively answered with future nanopore sequencing approaches.  
We previously observed a striking enrichment for two-exon genes in lncRNAs11. 
However, we have found that this is clearly an artefact arising from annotation 
incompleteness: the mean number of exons for lncRNAs in the FL models is 4.27, 
compared to 6.69 for mRNAs (Figure 5b, Supplementary Figure 13b). This difference is 
explained by lncRNAs’ longer exons, although they peak at approximately 150 bp, or one 
nucleosomal turn (Supplementary Figure 13c).  
Improvements in TSS annotation are further demonstrated by the fact that FL 
transcripts’ TSSs are, on average, closer to expected promoter features, including 
promoters and enhancers predicted by genome segmentations42 and CpG islands, 
although not evolutionarily-conserved elements or phenotypic GWAS sites43 (Figure 5c). 
Accurate mapping of lncRNA promoters may provide new hypotheses for the latter’s 
mechanism of action. For example, improved 5’ annotation strengthens the link between 
GWAS SNP rs246185, correlating with QT-interval and lying in the promoter of heart- 
and muscle-expressed RP11-65J2 (ENSG00000262454), for which it is an expression 
quantitative trait locus (eQTL)44 (Supplementary Figure 13d-e). 
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Improved 5’ definition provided by CLS transcript models also allows us to 
compare lncRNA and mRNA promoters. Recent studies, based on the start position of 
gene annotations, have claimed to observe strong differences between lncRNA and 
mRNA promoters45,46. To make fair comparisons, we created an expression-matched set 
of mRNAs in HeLa and K562 cells, and removed bidirectional promoters. These were 
compared across a variety of datasets from ENCODE12 (Supplementary Figures 14, 15).  
We observe a series of similar and divergent features of lncRNAs’ and mRNAs’ 
promoters. For example, activating promoter histone modifications such as H3K4me3 
(Figure 5d) and H3K9ac (Figure 5e), are essentially indistinguishable between full-length 
lncRNAs (dark blue) and protein-coding genes (red), suggesting that, when accounting 
for expression differences, active promoter architecture of lncRNAs is not unique. The 
contrast of these findings with previous reports, suggest that the latter’s reliance on 
annotations alone led to inaccurate promoter identification45,46.  
On the other hand, and as observed previously, lncRNA promoters are 
distinguished by elevated levels of repressive chromatin marks, such as H3K9me3 
(Figure 5f) and H3K27me345 (Supplementary Figures 14, 15). This may be the 
consequence of elevated recruitment to lncRNAs of the Polycomb Repressive Complex, 
as evidenced by its subunit Ezh2 (Figure 5g). Promoters of lncRNAs are also 
distinguished by a localised peak of insulator protein CTCF (Figure 5h). Finally, there is 
a clear signal of evolutionary conservation at lncRNA promoters, although lower than for 
protein-coding genes (Figure 5i). 
Two conclusions are drawn. First, that CLS-inferred TSS have greater density of 
expected promoter features, compared to probed annotations, demonstrating that CLS 
improves TSS annotation. And second, that when adjusting for expression, lncRNA have 
similar activating histone modifications, but distinct repressive modifications, compared 
to protein-coding genes.  
 
Discovery of new potential open reading frames 
 
A number of studies have suggested that lncRNA loci encode peptide sequences 
through unannotated open reading frames (ORFs)47,48. We searched for signals of protein-
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coding potential in FL models using two complementary methods, based on evolutionary 
conservation and intrinsic sequence features49,50 (Figure 6a, Methods, Supplementary 
Data 1). This analysis finds evidence for protein-coding potential in a small fraction of 
lncRNA FL TMs (109/1271=8.6%), with a similar number of protein-coding FL TMs 
displaying no evidence of encoding protein (2900/42,758=6.8%) (Figure 6b).  
CLS FL models support a reclassification of protein-coding potential for five distinct gene 
loci (Figure 6c, Supplementary Figure 16a, Supplementary Data 2). A good example is 
the KANTR locus, where extension by CLS (supported by independent RT-PCR) 
identifies a placental mammal-conserved 76aa ORF with no detectable protein 
orthologue51. It is composed of two sequential transmembrane domains (Figure 6d, 
Supplementary Figure 16e), and derives from a LINE1 transposable element. Another 
case is LINC01138, linked with prostate cancer, where a potential 42 aa ORF is found in 
the extended transcript52. We could not find peptide evidence for translation of either 
ORF (see Methods). Whole-cell expression, as well as cytoplasmic-to-nuclear 
distributions, also showed that potentially protein-coding lncRNAs’ behaviour is 
consistently more similar to annotated lncRNAs than to mRNAs (Supplementary Figures 
16b-d). Hence, CLS will be useful in improving biotype annotation of the small minority 
of lncRNAs that may encode proteins.   
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Discussion 
 
We have introduced an annotation methodology that resolves the competing needs 
of quality and throughput. Capture Long Read Sequencing produces transcript models 
with quality approaching that of human annotators, yet with throughput comparable to in-
silico transcriptome reconstruction. CLS improves upon existing assembly-based 
methods not only due to confident exon connectivity, but also through (1) far higher rates 
of 5’ and 3’ completeness, and (2) carrying encoded polyA tails. 
In economic terms, CLS is also competitive. Using conservative estimates, with 
2016 prices ($2460 for 1 lane of PE125bp HiSeq, $500 for 1 SMRT), and including the 
cost of sequencing alone, we estimate that CLS yielded one novel, full-length lncRNA 
structure for every $8 spent, compared to $27 for conventional CaptureSeq. This 
difference is due to the greater rate of full-length transcript discovery by CLS.  
Despite its advantages, CLS remains to be optimised in several respects. First, the 
capture efficiency for long cDNAs can be improved by several-fold. Second, various 
technical factors limit the completeness of CLS TMs, including: sequencing reads that 
remain shorter than many transcripts; incomplete reverse transcription of the RNA 
template; degradation of RNA molecules before reverse transcription. Resolving these 
issues will be important objectives of future protocol improvements, and only then can 
we make definitive judgements about lncRNA transcript properties. In recent, 
unpublished work we have further optimised the capture protocol, pushing on-target rates 
to around 35% (see details in Methods). However the most dramatic gains in cost-
effectiveness and completeness of CLS will be made by advances in sequencing 
technology. The latest nanopore cDNA sequencing promises to be ~150-fold cheaper per 
read than PacBio technology (0.01 vs 15 cents/read, respectively). 
Full-length annotations have provided the most confident view to date of lncRNA 
gene properties. These are more similar to mRNAs than previously thought, in terms of 
spliced length and exon count11.  A similar trend is seen for promoters: when lncRNA 
promoters are accurately mapped by CLS and compared to expression-matched protein-
coding genes, we find them to be surprisingly similar for activating modifications. This 
suggests that previous studies, which placed confidence in annotations of TSS, should be 
reassessed45,46. On the other hand lncRNA promoters do have unique properties, 
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including elevated levels of repressive histone modification, recruitment of Polycomb 
group proteins, and interaction with the insulator protein CTCF. To our knowledge, this 
is the first report to suggest a relationship between lncRNAs and insulator elements. 
Overall, these results suggest that lncRNA gene features per se are generally comparable 
to mRNAs, after normalising for their differences in expression. Finally, extended TMs 
do not yield evidence for widespread protein-coding capacity encoded in lncRNAs. 
Despite success in mapping novel structure in annotated lncRNAs, we observed 
surprisingly low numbers of transcript models originating in the relatively fewer numbers 
of unannotated loci that we probed, including ultraconserved elements and developmental 
enhancers. This would suggest that, at least in the tissue samples probed here, such 
elements do not give rise to substantial numbers of lncRNA-like, polyadenylated 
transcripts. 
In summary, by resolving a longstanding roadblock in lncRNA transcript 
annotation, the CLS approach promises to accelerate progress towards an eventual 
“complete” mammalian transcriptome annotation. These updated lncRNA catalogues 
represent a valuable resource to the genomic and biomedical communities, and address 
fundamental issues of lncRNA biology.  
URLs 
 
CLS data portal: https://public_docs.crg.es/rguigo/CLS/. 
Pre-loaded CLS UCSC Genome Browser track hub: http://genome-euro.ucsc.edu/cgi-
bin/hgTracks?hubUrl=http://public_docs.crg.es/rguigo/CLS/data/trackHub//hub.txt 
CodAlignView: https://data.broadinstitute.org/compbio1/cav.php. 
ENCODE mycoplasma contamination guidelines: 
https://www.encodeproject.org/documents/60b6b535-870f-436b-8943-
a7e5787358eb/@@download/attachment/Cell_Culture_Guidelines.pdf 
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 Figure legends 
 
Figure 1: Capture Long Seq approach to extend the GENCODE lncRNA 
annotation 
 
a)  Strategy for automated, high-quality transcriptome annotation. CLS may be used 
to complete existing annotations (blue), or to map novel transcript structures in 
suspected loci (orange). Capture oligonucleotides (black bars) are designed to tile 
across targeted regions. PacBio libraries are prepared for from the captured 
molecules. Illumina HiSeq short-read sequencing can be performed for 
independent validation of predicted splice junctions. Predicted transcription start 
sites can be confirmed by CAGE clusters (green), and transcription termination 
sites by non-genomically encoded polyA sequences in PacBio reads. Novel exons 
are denoted by lighter coloured rectangles.  
b) Summary of human and mouse capture library designs. Shown are the number of 
individual gene loci that were probed. “PipeR pred.”: orthologue predictions in 
mouse genome of human lncRNAs, made by PipeR29; “UCE”: ultraconserved 
elements; “Prot. coding”: expression-matched, randomly-selected protein-coding 
genes; “ERCC”: spike-in sequences; “Ecoli”: randomly-selected E. coli genomic 
regions. Enhancers and UCEs are probed on both strands, and these are counted 
separately. “Total nts”: sum of targeted nucleotides.  
c)  RNA samples used. 
 
Figure 2: CLS yields an enriched, long-read transcriptome 
 
a) Sequencing statistics. ROI = “Read Of Insert”, or PacBio reads.  
b) Length distributions of ROIs. Sequencing libraries were prepared from three size-
selected cDNA fractions (see Supplementary Figure 1b-c). 
c) Breakdown of sequenced reads by gene biotype, pre- (left) and post-capture 
(right), for human (equivalent mouse data in Supplementary Figure 2j). Colours 
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denote the on/off-target status of the reads: Green: reads from targeted features, 
including lncRNAs; Grey: reads originating from annotated but not targeted 
features; Yellow: reads from unannotated, non-targeted regions. The ERCC class 
comprises only those ERCC spike-ins that were probed. Note that when a given 
read overlapped more than one targeted class of regions, it was counted in each of 
these classes separately. 
d) Summary of capture performance. The y-axis shows percent of all mapped ROIs 
originating from a targeted region (“on-target”). Enrichment is defined as the ratio 
of this value in Post- and Pre-capture samples. Sequencing was performed using 
MiSeq technology. 
e) Response of read counts in captured cDNA to input RNA concentration. Upper 
panels: Pre-capture; Lower panels: Post-capture. Left: human; right: mouse. Note 
log scales for each axis. Points represent 92 spiked-in synthetic ERCC RNA 
sequences. 42 were probed in the capture design (green), the other 50 were not 
(violet). Lines represent linear fits to each dataset, whose parameters are shown. 
Given the log-log representation, a linear response of read counts to template 
concentrate should yield an equation of type y = c + mx, where m is 1. 
 
Figure 3: Extending known lncRNA gene structures 
 
a) Novel transcript structures from the SAMMSON locus. Green: GENCODE; 
Black/Red: known/novel CLS transcript models (TMs), respectively. An RT-
PCR-amplified sequence is shown.   
b) Splice junction (SJ) discovery. Y-axis: unique SJs for human (mouse data in 
Supplementary Figure 6b) within probed lncRNA loci. Grey: GENCODE-
annotated, CLS-undetected SJs. Dark green: CLS-detected, GENCODE-
annotated SJs. Light green: novel CLS SJs. Left: all SJs; Right: high-confidence, 
HiSeq-supported SJs. See Supplementary Figure 6c for comparison to the 
miTranscriptome catalogue.  
c) Splice junction (SJ) motif strength. Panels plot the distribution of predicted SJ 
strength, for splice site (SS) acceptors (left) and donors (right) in human (mouse 
data in Supplementary Figure 7a). SS strength was computed using GeneID37. 
.CC-BY 4.0 International licensenot peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/105064doi: bioRxiv preprint first posted online Feb. 1, 2017; 
Data are shown for non-redundant CLS SJs from targeted lncRNAs (top), protein-
coding genes (middle), or randomly-selected SS-like dinucleotides (bottom). 
d) Splice junction discovery/saturation analysis in human. Panels show novel SJs 
discovered (y-axis) in simulations with increasing numbers of randomly sampled 
CLS ROIs (x-axis). SJs retrieved in each sample were stratified by level of support 
(Brown: all PacBio SJs; Orange: HiSeq-supported; Black: HiSeq-unsupported). 
Boxplots summarise 50 samples. Equivalent mouse data in Supplementary Figure 
8a, and for novel TM discovery in Supplementary Figure 8b.  
e)  Identification of putative precursor transcripts of small RNA genes. For each 
gene biotype, figures show the count of unique genes. “Orphans”: no annotated 
overlapping transcript in GENCODE, and targeted in capture library. “Potential 
Precursors”: orphan RNAs residing in the intron of a novel CLS TM. 
“Precursors”: reside in the exon of a novel transcript.  
 
Figure 4: Full-length transcript annotation 
 
a) 5’ and 3’ termini of transcript models (TMs) are inferred using CAGE clusters 
and polyA tails in ROIs, respectively.  
b)  In conventional transcript merging (CM) (left), TSSs and polyA sites overlapping 
other exons are lost. “Anchored merging” (AM) (right) preserves such sites. 
c)  AM yields more distinct TMs. y-axis: ROI count (pink), AM-TMs (brown), CM-
TMs (turquoise).  
d)  Full-length (FL) TMs at the CCAT1 / CASC19 locus. Red: novel FL TMs. 
Green/Red stars: CAGE/polyA-supported ends, respectively. An RT-PCR-
amplified sequence is shown.  
e) AM-TMs for human (mouse data in Supplementary Figure 11b). y-axis: unique 
TM counts. Left: All AM-TMs, coloured by end support. Middle: FL TMs, 
coloured by novelty w.r.t. GENCODE. Green: novel TMs (see Methods for 
subcategories). Right: Novel FL TMs, coloured by biotype.  
f) Numbers of probed lncRNA loci mapped by CLS at increasing cutoffs for each 
category (human) (mouse data in Supplementary Figure 11c).  
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g) DHS coverage of TSSs in HeLa-S3. y-axis: mean DHS density per TSS. Grey 
fringes: S.E.M. “CAGE+” / “CAGE-“: CLS TMs with / without supported 5’ 
ends, respectively. “GENCODE protein-coding”: TSSs of protein-coding genes. 
h)  Comparing lncRNA transcript catalogues from GENCODE, CLS, and StringTie 
within captured regions. Mouse data in Supplementary Figure 12b-e. 
i) 5’/3’ transcript completeness, estimated by CAGE and upstream polyadenylation 
signals (PAS), respectively (human). Shown is the proportion of transcript ends 
with such support (“CAGE(+)”/”PAS(+)”).  “Control”: random sample of internal 
exons. Mouse data in Supplementary Figure 12f. 
j) Spliced length distributions of transcript catalogues. Dotted line: median. Mouse 
data in Supplementary Figure 12c. 
 
Figure 5: Discovery of novel lncRNA transcripts 
 
a)  The mature, spliced transcript length of: CLS full-length transcript models from 
targeted lncRNA loci (dark blue); transcript models from the targeted and detected 
GENCODE lncRNA loci (light blue); CLS full-length transcript models from 
protein-coding loci (red).  
b)  The numbers of exons per full length transcript model, from the same groups as 
in (a). Dotted lines represent medians. 
c)  Distance of annotated transcription start sites (TSS) to genomic features. Each 
cell displays the mean distance to nearest neighbouring feature for each TSS. TSS 
sets correspond to the classes from (a). “Shuffled” represent FL lincRNA TSS 
randomly placed throughout genome.  
d)  – (i) Comparing promoter profiles across gene sets. The aggregate density of 
various features is shown across the TSS of indicated gene classes. Note that 
overlapping TSS were merged within classes, and TSSs belonging to bi-
directional promoters were discarded (see Methods). The y-axis denotes the mean 
signal per TSS, and grey fringes represent the standard error of the mean. ChIP-
Seq experiments are from HeLa cells (see Methods). phastCons17way: 
conservation scores across 17 vertebrate species. Gene sets are: Dark blue, full-
length lncRNA models from CLS; Light blue, the GENCODE annotation models 
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from which the latter were probed; Red, a subset of protein-coding genes with 
similar expression in HeLa as the CLS lncRNAs. 
 
Figure 6: Properties of full-length lncRNAs 
 
a) The predicted protein-coding potential of all full-length transcript models mapped 
to lncRNA (left) or protein-coding loci (right). Points represent full length (FL) 
transcript models (TM). y-axis displays the coding likelihood according to 
PhyloCSF, based on multiple genome alignments; x-axis displays that calculated 
by CPAT, an alignment-free method. Red lines indicate score thresholds, above 
which are considered protein-coding. TMs mapping to multiple biotypes were not 
considered. 
b)  Numbers of classified TMs from (a).  
c)  Discovery of new protein-coding transcripts in full-length CLS reads, using 
PhyloCSF. x axis: For each probed GENCODE gene annotation, score of best 
ORF across all transcripts; y axis: Score of best ORF in corresponding FL CLS 
TMs. Yellow: Loci from GENCODE v20 annotation predicted to encode proteins 
are highlighted. Red: LncRNA loci where new ORFs are discovered as a result of 
CLS transcript models. 
d) KANTR, example of an annotated lncRNA locus novel protein-coding sequence 
is discovered. The upper panel shows the structure of the lncRNA and the 
associated ORF (highlighted region) falling within novel FL CLS transcripts 
(red). Note how this ORF lies outside existing annotation (green), and overlaps a 
highly-conserved region (see PhastCons conservation track, below). Shown is a 
sequence obtained by RT-PCR (black). The lower panel, generated by 
CodAlignView (see URLs), reveals conservative substitutions in the predicted 76 
aa ORF consistent with a functional peptide. High-confidence predicted 
SMART53 domains are shown as coloured bars below. This ORF lies within and 
antisense to a L1 transposable element (grey bar).  
.CC-BY 4.0 International licensenot peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/105064doi: bioRxiv preprint first posted online Feb. 1, 2017; 
Online Methods 
 
Abbreviations 
FL: full length 
HCGM: High-Confidence Genome Mapping 
ROI: read of insert, i.e. PacBio reads 
SJ: splice junction 
SS: splice site 
TM: transcript model 
TSS: Transcription Start Site 
UMD-ROI: Uniquely Mapped and Demultiplexed ROI 
 
Library Design 
 
Design of human capture probes 
All designs were based on the GENCODE10 version 20 annotation in human 
genome build hg38. For probe design, a target annotation was prepared in FASTA format 
and composed of the following sets of features. In each case, the entire set of feature of 
each class was taken as a starting point, unless otherwise stated, and where necessary 
were lifted over to the hg38 assembly. Features overlapping protein coding gene loci were 
removed. Intergenic lncRNAs were extracted from the GENCODE v20 annotation, being 
all those genes having no single transcript that overlaps or lies within 5 kb of any protein-
coding gene. For small RNA loci, a 1 kb window centered on the small RNA was targeted. 
At this stage, the expression of candidate regions was quantified using 
HBM/ENCODE RNA-Seq data from appropriate human tissues and cell lines. We 
noticed that the top 20 most expressed features (mean expression across samples) 
produced approximately 71% of sequencing reads (Supplementary Figure 17) – these 
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were removed, in order to favour rarer transcripts. A number of controls were added to 
the design. 100 protein coding genes, with steady-state levels matched to the distribution 
of lncRNAs, were included. 100 random genomic regions of 1 kb from the E. coli genome 
were included. 100 intergenic regions of 1 kb each with no evidence from ENCODE 
ChromHMM for any transcriptional or regulatory activity54 . Finally, out of the 92 ERCC 
sequences, we removed the top 8 most concentrated, and selected half (42) of the 
remainder such that they evenly covered the concentration distribution. In total the design 
targeted 14,667 regions, which corresponded to ~15.5 Mb of human genome (hg38) and 
exons of 9,560 lincRNAs from 5,953 loci. The summary information for selected 
transcript targets in human is provided in Supplementary Table 4. Statistics on probed 
gene loci are presented in Figure 1b.  
All targets were combined into a single FASTA file and submitted to Roche 
NimbleGen (Madison, WI) for probe design. The oligonucleotide-probes were designed 
and synthesised as a SeqCap EZ Choice XL Library according to manufacturer’s protocol. 
The oligonucleotide probes covered 86.6% of target regions directly, with an estimated 
96.1% of target regions successfully targeted. Roche Nimblegen’s policy prohibited 
release of SeqCap’s probe coordinates, but the design is available on request. 
 
Design of mouse capture probes 
Mouse library design was carried out essentially as for human with the following 
differences. All designs were based on the GENCODE version M3 annotation in genome 
build mm10. Candidate lncRNAs were filtered to remove those overlapping any protein 
coding gene within 5kb. Homology-based predictions of mouse orthologues of human 
lncRNA were obtained using the PipeR pipeline29. As before, the top 20 most expressed 
lncRNAs, as estimated using RNAseq data from ENCODE31 were removed. The final 
design covered 8,708 regions, including 2,817 GENCODE vM3 lincRNA transcripts 
from 1,920 loci. The covered regions corresponded to 8.3 Mb. The summary information 
for selected transcript targets in mouse is provided in Supplementary Table 5. Statistics 
on probed gene loci are presented in Figure 1b. 
Designed oligonucleotide probes covered 76.3% of target regions directly and 85.0 
% of target regions successfully targeted. Oligonucleotide-probes were synthesised as a 
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Roche NimbleGen SeqCap EZ Choice XL Library. Roche Nimblegen’s policy prohibited 
release of SeqCap’s probe coordinates, but the design is available on request. 
 
Sample Preparation 
 
RNA samples 
Commercial total RNA samples were obtained for 4 different adult human (Ambion 
AM6000) and mouse (Clontech 636644) tissues: heart, testes, liver and brain. From the 
same panel also came mouse E7 and E15 samples. Human K562 and HeLa RNA was 
obtained directly from members of the ENCODE consortium31. Neither cell line used in 
this paper is listed in the database of commonly misidentified cell lines maintained by 
ICLAC. Cell lines were not authenticated. Cell lines were tested for mycoplasma 
contamination as per ENCODE guidelines (see URLs). The integrity of samples were 
tested by Bionanalyzer (Agilent) and all had values of 8.5 or higher. To 4 μg of each RNA 
sample, we added 4 μl of 1:100 diluted ERCC mix (Ambion 4456740) according to 
manufacturer’s protocol (Supplementary Table 6). Mix 1&2 were assigned to samples as 
shown below. The samples containing ERCC controls were ribodepleted with Ribo-Zero 
(Epicentre MRZE724), and successful rRNA removal was validated by Bioanalyzer. 
 
cDNA synthesis 
Full-length cDNA was synthetized via reverse-transcription of ribosome-depleted RNA 
samples using SMARTer® PCR cDNA Synthesis Kit (Clontech 634926) and 
Advantage®2 PCR Kit (Clontech 639206). Each cDNA was synthetized using 3.5 μl of 
ribosome-depleted RNA according to manufacturer protocol, performing two 
independent cDNA synthesis reactions for each sample. It should be noted that cDNA 
was primed using oligodT. The adapter used in the cDNA library construction sequences 
(“SMART IV Oligonucleotide” and “CDS III/3' PCR Primer”) are to be found in 
Supplementary Data 3. 
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All first strand RNA obtained from the reaction was used for second strand synthesis. The 
synthesis cycling protocol was modified from that specified by the manufacturer, 
increasing the extension time from 3 to 6 minutes to favour the synthesis of long strands. 
After protocol optimization, a total of 18 cycles were used to obtain the full-length cDNA 
libraries. Resulting cDNA was quantified using NanoDrop® ND-1000 full-spectrum 
spectrophotometer (Thermo Scientific). The library length and quality was also verified 
by Bioanalyzer. 
 
Capture 
 
Library Preparation 
cDNA samples were used to create barcoded, full length libraries. The two aliquots 
of cDNA obtained in the preceding step were pooled, of which 1 ug was used for library 
preparation. One adenine was added to blunt cDNA 3' extremities and Illumina Truseq 
adapters were ligated. Different barcoded adaptor hexamer indexes were used to 
discriminate each sample (Supplementary Table 7 and Supplementary Data 3). The 
overall structure of cDNA libraries is represented schematically in Supplementary Figure 
2c.  
The library was amplified for 10 PCR cycles modifying standard Kapa Biosystems 
PCR conditions (Low throughput Library prep - Kapa Biosystems KK8232). The PCR 
extension step was increased to 3 min to allow long fragments to be fully amplified. The 
quality and the length of libraries was checked using Agilent 2100 Bioanalyzer. Library 
quantification was performed using Qubit® dsDNA BR assays (ThermoFisher). For each 
cDNA sample, an additional Covaris-fragmented, Illumina sequencing library was 
prepared for MiSeq and HiSeq sequencing according to standard protocols. 
Standard Illumina 6mer indexes were used here, to be compatible with blocking 
oligonucleotides in the SeqCap capture protocol (see below). It should be pointed out that 
the use of these relatively short indexes led to loss of information during later 
demultiplexing steps. Improving this issue by using standard 16-nt PacBio indexes should 
be a priority in future versions of CLS.  
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Sample pooling 
Samples were pooled separately by species, such that all 6 human libraries were mixed at 
equimolar ratios, and similarly for mouse. The final amount of each pool was one 
microgram. 
 
cDNA capture 
Human and mouse pools were dried and prepared for hybridisation to NimbleGen 
SeqCap EZ Choice XL Library capture probes, according to manufacturer’s protocol 
(SeqCap EZ Library SR User’s Guide - Version 5.0). Hybridisation was carried out for 
72 hours. Altogether 5 separate, parallel captures were performed for each species: 4 were 
used for subsequent PacBio sequencing, with one remaining sample used for Illumina 
sequencing. 
Subsequent to the presented work, we have managed to further optimise the 
efficiency of this capture process, by implementing four changes to the described 
protocol:  
1. Drying cDNA for resuspension prior to capture: temperature at 60°C instead of 
55°C. 
2. Hybridisation incubation time: 20h instead of 72h. 
3.  Washing steps after capture: use of water bath instead of dry bath. 
4. Blockers: Additional blockers targeting the SMARTer adaptors used during 
library construction (sequences in Supplementary Data 3, “SMARTer_blocker” and 
“SMARTer_5p_PCR_blocker”). 
 
Amplification and quality control of captured cDNA 
Following hybridisation, human and house pools were washed to eliminate 
nonspecific hybridization using m-280 streptavidin Dynabeads (Invitrogen 11205D) 
following recommendations of Roche protocol.  Human and Mouse washed pools were 
PCR amplified using KAPA HotStart ReadyMix- 2X (KapaBiosysthems KK1006). Two 
independent PCR reactions containing half of washed pool each were prepared to avoid 
PCR duplicates. 18 cycles of PCR were performed, with an increased extension step of 3 
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minutes to allow long fragments to be fully amplified.  The length of post-capture PacBio 
and Illumina libraries was verified by Bioanalyzer, and quantity by Qubit. 
 
Pacific Biosciences (PacBio) Sequencing of Captured cDNA 
 
Pooling 
After quantification and quality control the 4 post-capture libraries were pooled 
together by species to obtain one unique human and one unique mouse pool. The 110 μl 
of each sample were again quantified by Qubit® dsDNA BR assays (ThermoFisher): 12.3 
μg for human and 9.57 μg for mouse.  
 
Size Selection 
Samples were subsequently size-selected using E-gel (Invitrogen) to obtain 3 
different ranges: 1000-1500 bp, 1500-2500 bp and >2500 bp. Two shorter fractions of 
200-500 bp, 500-1000 bp were collected, but following preliminary sequencing data, it 
was decided not to scale them up, due to the large number of reads in this size range 
obtained in the larger fractions. Following size selection, each size fraction was dried and 
resuspended with 20 μl of water and quantified by Qubit® dsDNA BR assays 
(ThermoFisher). These samples were then amplified again by PCR (4 cycles) using Kapa 
HiFi HotStart (kapaBiosystems) in order to reach the required amount for PacBio library 
preparation. The quality and the length of obtained libraries was verified using 
Bioanalyzer and Qubit.  
The efficiency of size selection was also checked by analysis of spike-in sequences 
(Supplementary Figure 1d). For each size-selected captured library, and for pre-capture 
libraries, the sequencing efficiency was calculated as a function of spike-in sequence 
length. Sequencing efficiency was defined for each spike-in sequence as: (Number of 
reads) / (molar concentration * sequence length * total read count). This showed that, as 
expected, size-selection boosted the sequencing of longer templates. 
 
 PacBio library preparation 
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Approximately 2μg of each of the size-fractionated and amplified DNA was used 
for each of human and mouse pools, for a total of 6 (3x2) distinct samples.  Sizes and 
concentrations were verified by Bioanalyzer. PacBio libraries were constructed for each 
sample using Kit #100-250-100 (Pacific Biosciences Inc.) as per the manufacturer’s 
protocol.  Briefly, this involves polishing the PCR amplicon ends to ‘blunt’ them, ligating 
the SMRTbell adapters, removing linear (non-ligated) fragments of DNA, AMPure bead 
purification, followed by Bioanalyzer analysis to assess the size distribution and Qubit 
quantifications. 
 
PacBio sequencing and collection of Post-Capture data 
The PacBio libraries were each run on an initial SMRTcell to assess their respective 
performance and optimal sequencing concentration.  Those that performed well were then 
scaled-up to an additional 20 SMRTcells for deep data collection. The PacBio reagents 
and metrics used for each sample are listed in Supplementary Table 8. The sequencing 
was performed on a PacBio RSII instrument. Upon completion of the sequencing, 
SMRTcells from a given library were aggregated on the SMRTportal and the PacBio 
post-processing method “RS_ReadsOfInsert.1” were run on each aggregated sample to 
obtain Reads of Inserts (ROIs) for downstream processing.  This yielded a single FASTQ 
file per library.  
 
 
HiSeq sequencing of Captured cDNA 
 
Post-capture Illumina cDNA libraries were sequenced on a HiSeq 2500 machine 
(2x125 nucleotides, v4, high output mode). One sequencing lane was generated per 
species at a depth of ~212M (human) and ~156M (mouse) pairs of reads. Read pairs were 
demultiplexed using Illumina software. Note that these libraries were unstranded, and 
Covaris-fragmented before capture. 
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Demultiplexing of ROIs according to sample barcodes 
 
As previously mentioned, PacBio reads contained Illumina Truseq adapters: 
universal (59 nt) and indexed (65 nt) that flank targeted cDNAs (Supplementary Figure 
2c). To demultiplex samples (i.e., determine the tissue of origin of each ROI), for each 
adapter its middle 26-nt was selected. Each of the 26-mers derived from the indexed 
adapters contained the hexamer barcode in the center. GEM mapper55 was employed to 
demultiplex samples. PacBio reads were compiled into a FASTA file (one file per 
species) and indexed by GEM. Mapping the middle 26-mer of indexed adapters to the 
PacBio read allowed us to assign it its tissue origin. The additional presence of the 
universal adapter within ROIs was used to confirm the completeness of the insert. The 
GEM-based demultiplexing procedure allowed up to 3 mismatches (-m 0.1) and 3 
indels (-e 0.1), accurate identification of the barcodes. Following non-default GEM 
parameters were used during the mapping step: -T 3 --max-big-indel-length 
0 -s 3 -D 4. We filtered out “chimeric” ROIs (that is, reads arising from the 
concatenation of inserts during adapter ligation) by removing those reads that contained 
more than one indexed or more than one Universal TruSeq Illumina adapter sequence. 
Overall, we could demultiplex 1,627,322 and 1,509,374 ROIs in human and mouse, 
respectively (Figure 2a and Supplementary Figure 2b). As presented in Supplementary 
Figure 2d, only a minute fraction of human ROIs were assigned a mouse barcode (and 
reciprocally), underlining the high specificity of the demultiplexing procedure. 
 
Read mapping 
 
All read-to-genome alignments were performed on genome assemblies 
GRCh38/hg38 (human) and GRCm38/mm10 (mouse). Mapping of ROIs from post-
capture PacBio libraries to human and mouse genomes (in addition to sequences of 96 
ERCC Spike-In Controls) was carried out using STAR56 (v.2.4.0.1) compiled for long 
reads. To improve splice junction mapping accuracy, a reference annotation was provided 
as a guide to the aligner. Reference annotation for human was built using GENCODE v20 
set and sequences of all other targeted regions. For mouse, exonic sequences of PipeR 
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predictions along with sequences of all other additional targets were added to the 
reference annotation of GENCODE vM3. The following non-default parameters where 
used during the mapping step: --outFilterMultimapScoreRange 20 --
outFilterScoreMinOverLread 0 --outFilterMatchNminOverLread 
0.5 --outFilterMismatchNmax 1000 --winAnchorMultimapNmax 200 
--seedSearchStartLmax 50 --seedPerReadNmax 100000 --
seedPerWindowNmax 100 --alignTranscriptsPerReadNmax 100000 
–alignTranscriptsPerWindowNmax --genomeSAsparseD 4 --
outSAMunmapped Within --runThreadN 6. 
For analysis of MiSeq  (pre-capture cDNA) and HiSeq (post-capture) data, FASTQ 
files were aligned to the human and mouse genomes (plus the sequences of 96 ERCC 
Spike-In Controls), using STAR56 (v.2.4.0.1) compiled for short reads. Again the 
reference annotations described above were employed to guide the mapper. In order to 
maximize the mapping rate, the mates of each pair of reads were aligned separately. The 
following non-default STAR parameters were specified:  
--outFilterMismatchNoverLmax 0.04 --alignIntronMin 20 --
alignIntronMax 1000000 --alignMatesGapMax 1000000 --
outSAMunmapped Within --runThreadN 6. HiSeq mapping statistics are 
summarized in Supplementary Figure 2l. 
 
Analysis of CLS performance, on-target enrichment 
 
RNA capture on-target enrichment 
The overall RNA capture performance was evaluated by calculating an on-target rate 
in both MiSeq pre- and PacBio post-capture libraries. The on-target rate was defined as 
the ratio of the number of distinct ROIs mapping into targeted genomic regions (excluding 
ERCC RNA spike-in controls) over the total number of mapped ROIs. The number of 
reads overlapping targeted regions was calculated directly from the STAR BAM file 
using bedtools intersect57. Overlap was defined as ≥1 bp of intersection between 
the sequencing read and the exonic span of a feature, on the same strand. The overall on-
target fold enrichment was computed as the on-target rate in the post-capture library, 
divided by the on-target rate in the pre-capture library.  
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Enrichment was calculated separately by reference to two distinct sequencing 
datasets of post-capture cDNA: (a) the main PacBio reads; (b) Illumina MiSeq of the 
same material. Figure 2d shows data for enrichments calculated using the latter data: 
MiSeq post-capture vs MiSeq pre-capture. Equivalent enrichments for the former 
comparison (PacBio post-capture vs MiSeq pre-capture) are: 16.6- / 11.1-fold, for 
human/mouse. 
We compared CLS enrichments to a previous Capture Short-read Sequencing (CSS) 
study24. We focused our analysis on the CSS tissues that were also assayed in CLS (that 
is, human Brain, Heart, Liver and Testis), and computed on-target rates on lincRNAs 
more than 5kb away from any protein-coding gene in both studies, based on GENCODE 
v20 and v19 for CLS and CSS, respectively. CSS pre-capture rates were estimated using 
pre-capture MiSeq libraries generated in the present work, and remapped to hg19 / 
GENCODE 19. Across the 4 tissues studied, CLS outperformed CSS both in terms of on-
target enrichment (in all samples) and post-capture on-target rate (in Brain and Testis 
only) (Supplementary Figure 2f-g).  
Breakdown of sequencing reads by gene biotype 
Both the human and mouse genomes, as well as ERCC spike-in sequences, were 
segmented into distinct classes of locus regions, according to their gene biotype 
annotation and capture status (i.e., On-target vs Off-target). The on- and off-target 
categories correspond to standard, GENCODE-annotated gene biotypes (in simplified 
categories, as described in the Supplementary Note, in addition to “Other”, which 
comprises mitochondrial genes),, while the “Intergenic” class includes all non-targeted 
and unannotated genome segments. Next, we calculated the proportion of pre- and post-
capture MiSeq reads originating from each genome partition using the read BAM files 
and the bedtools coverage utility57. Note that when a given read overlapped 
multiple regions of distinct biotype classes, it was counted in each of these classes 
separately. Secondary targets (i.e., genes not targeted per se, yet overlapping targeted 
regions) were included in on-target biotype sub-classes. The following additional 
hierarchical rules were applied in the assignment: the highest priority in the read 
classification was given to capture-targeted (“On-target”), then “Off-target”, and finally 
“Intergenic” classes; these three categories are mutually exclusive.  
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Comparison of capture protocols and long cDNA capture efficiency 
We wished to compare the performance of the CLS protocol to other methods. 
Performance was judged by (1) the % of reads in post-capture cDNA originating from a 
targeted region (“on-target” rate), and (2) the enrichment, defined as the ratio of on-target 
rates in post/pre capture cDNA. In all experiments, the off-the-shelf SeqCap RNA 
lncRNA Enrichment Kit (Roche) was used. Four distinct experiments were performed. 
For each one, the same aliquot of human kidney total RNA was used, and sequencing was 
performed using Illumina MiSeq. The experiments were: 
1) Original CLS protocol (as used and described here), PolyA-selected, unfragmented. 
2) Improved CLS protocol, PolyA-selected, unfragmented. 
3) Improved CLS protocol, Total RNA, unfragmented. 
4) Roche SeqCap RNA protocol, Total RNA, fragmented.  
“Improved” CLS incorporated several adjustments designed to boost enrichment: use of 
Lo-bind tubes, drying step at 60⁰C, shorter incubation time, use of Smarter blockers, use 
of water bath at 47ºC for post capture washes.  
Findings are presented in Supplementary Figure 2h-i, and together suggest that capturing 
long cDNAs yields lower on-target efficiency. 
Supplementary Methods 
Available in the Supplementary Note. 
Code availability 
 
All computer code used in this study is available from the authors upon request. 
Most programs are deposited on GitHub, as specified in the relevant sections of the text. 
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Data availability 
 
Raw and processed data is deposited in the Gene Expression Omnibus under accession 
GSE93848. RT-PCR validation sequences are available as Supplementary Data 4. 
Genome-aligned data were assembled into a public Track Hub, which can be loaded into 
the UCSC Genome Browser (see URLs). 
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